Clinical Trial Update: Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

View source ↗

Summary

An observational clinical trial update evaluating bone complications in post-menopausal breast cancer patients who have stopped denosumab and aromatase inhibito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)
• Denosumab (denosumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: RECRUITING